CAS: 1150701-66-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK1940029 REF: TM-T5427CAS: 1150701-66-8 | 98.72% - 99.48% | 35.00 €~458.00 € | Fri 27 Dec 24 |
 | GSK1940029 REF: 3D-AWB70166CAS: 1150701-66-8 | Min. 95% | To inquire | Thu 16 Jan 25 |
 | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide REF: IN-DA008TPICAS: 1150701-66-8 | 98% | - - - | Discontinued product |
GSK1940029
CAS:1150701-66-8
GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor.
Formula:
C18H16Cl2N4O2
Purity:
98.72% - 99.48%
Color and Shape:
Solid
Molecular weight:
391.25
Ref: TM-T5427
| 1mg | 35.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 95.00 € | ||
| 25mg | 184.00 € | ||
| 50mg | 308.00 € | ||
| 100mg | 458.00 € | ||
| 1mL*10mM (DMSO) | 73.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
GSK1940029
CAS:1150701-66-8
GSK1940029 is a novel anti-inflammatory drug with a potency of about 150 times that of …
Formula:
C18H16Cl2N4O2
Purity:
Min. 95%
Molecular weight:
391.25 g/mol
Ref: 3D-AWB70166
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
![1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide](https://static.cymitquimica.com/products/IN/thumb/DA008TPI.jpg)
1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide
CAS:1150701-66-8
Formula:
C18H16Cl2N4O2
Purity:
98%
Molecular weight:
391.2512
Ref: IN-DA008TPI
| 1g | Discontinued | Request information | |
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
